June 2nd 2021
Elyse Lower, MD, discusses the importance of tucatinib in the treatment of patients with HER2-positive breast cancer.
May 17th 2021
Elyse Lower, MD, discusses the impact of tucatinib on the treatment of patients with HER2-positive breast cancer.